Table 1.
Gleason Score at Biopsy | |||||
---|---|---|---|---|---|
3 + 3 = 6 | 3 + 4 = 7 | 4 + 3 = 7 | ≥8 | P Value | |
Mean patient age (y) | 56.8 | 58.5 | 60.7 | 60.5 | .10 |
Mean prebiopsy PSA (ng/mL) | 6.4 | 5.9 | 8 | 7.7 | .24 |
Biopsy | |||||
Mean number of cores/cases | 10.9 | 11.6 | 9.4 | 9.2 | .07 |
Mean % core involvement | 16.1 | 24 | 19.5 | 39.2 | .002 |
Prostatectomy | |||||
Mean prostate size (cm) | 5.3 | 4.8 | 5.1 | 5.2 | .28 |
Extraprostatic extension (%) | 1 (4) | 2 (8) | 6 (30) | 12 (50) | <.001 |
Positive surgical margin (%) | 0 (0) | 0 (0) | 0 (0) | 5 (21) | .002 |
Seminal vesicle invasion (%) | 0 (0) | 0 (0) | 0 (0) | 3 (12) | .04 |
Lymphovascular invasion (%) | 0 (0) | 0 (0) | 0 (0) | 2 (8) | .17 |
Lymph node metastasis (%) | 0 (0) | 0 (0) | 0 (0)* | 1 (4) | .73 |
Lymph node dissection was not done in 1 patient of this group.